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Abstract
Background: Cancer surivors have limited knowledge about second primary cancer (SPC) screening and suboptimal rates of
completion of screening practices for SPC. Our objective was to test the efficacy of an educational material on the
knowledge, attitudes, and screening practices for SPC among cancer survivors.
Methods: Randomized, controlled trial among 326 cancer survivors from 6 oncology care outpatient clinics in Korea.
Patients were randomized to an intervention or an attention control group. The intervention was a photo-novel, culturally
tailored to increase knowledge about SPC screening. Knowledge and attitudes regarding SPC screening were assessed two
weeks after the intervention, and screening practices were assessed after one year.
Results: At two weeks post-intervention, the average knowledge score was significantly higher in the intervention
compared to the control group (0.81 vs. 0.75, P,0.01), with no significant difference in their attitude scores (2.64 vs. 2.57,
P=0.18). After 1 year of follow-up, the completion rate of all appropriate cancer screening was 47.2% in both intervention
and control groups.
Conclusion: While the educatinal material was effective for increasing knowledge of SPC screening, it did not promote
cancer screening practice among cancer survivors. More effective interventions are needed to increase SPC screening rates
in this population.
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Introduction
The high incidence of second primary cancers (SPC) [1,2] and
the impact of a SPC on survival [3] underscore the importance of
cancer screening in the increasing number of cancer survivors.
[4,5] Studies in the U.S. [6,7,8] and Korea [9] found that cancer
survivors were more likely to undergo cancer screening compared
to people without cancer, but the screening rates in cancer
survivors were still suboptimal [10]. There is thus considerable
interest in identifying effective interventions to increase screening
practices among cancer survivors. [9]
In a previous qualitative study, [11] we found that cancer
survivors frequently had not heard about SPC and could not
differentiate SPC from recurrence or metastasis of the primary
tumor. Cancer survivors were not aware of an increased risk of
SPC and had difficulty in distinguishing second cancer screening
from routine surveillance tests after cancer treatment. However,
they generally had positive attitudes towards cancer screening and
said that they would have undergone screening for SPC if they had
known about it. Overall, lack of knowledge seemed to be the
critical barrier for SPC screening in this population, and we
hypothesized simple intervention to cover such knowledge gap
would be effective.
Therefore, we designed a printed educational material that
incorporated cancer survivors’ perspectives to increase their
knowledge of SPC screening. This paper reports a multicenter
PLoS ONE | www.plosone.org 1 March 2012 | Volume 7 | Issue 3 | e33238randomized controlled trial that we conducted to assess the
efficacy of an educational material on SPC screening practice
among cancer survivors. As a secondary objective, we examined
the impact of the intervention on short-term knowledge and
attitudes about SPC.
Methods
The protocol for this trial and supporting CONSORT checklist
are available as supporting information; see Checklist S1 and
Protocol S1.
Study population
The trial was conducted in six specialized oncology care
outpatient clinics located at two cancer centers in the Seoul
metropolitan area, Korea. We included survivors of stomach,
colorectal, breast and thyroid cancers, based on the high incidence
and high 5-year survival rates of these cancers in Korea (Table
S1). [12] Subjects were eligible to participate if they were 40 to 79
years of age, had a histologically confirmed diagnosis of cancer
(stage I to III), had completed treatment for the primary cancer at
least one year ago at the time of recruitment, had no evidence of
recurrence, metastasis, or SPC, and had no evidence of hereditary
cancer. We excluded cancer survivors with poor general
performance status (Eastern Cooperative Oncology Group
[ECOG] $3) or who were unable to read Korean.
We used electronic medical records to identify survivors who
met the eligibility criteria and were scheduled to visit the
participating outpatient clinics in 2009. Among 646 eligible
cancer survivors who were approached during their regular follow-
up visits, 326 (50.3%) agreed to participate in the study. Study
participants were individually randomized to an intervention or an
attention control group (Figure 1). Randomization tables were
generated using a randomization program stratified by oncologist
with blocks of size four. The randomized assignments were not
revealed to study coordinators until after recruitment was
completed.
Ethics
Individual participants in this study gave written informed
consent. The study protocol was approved by the Institutional
Review Board of each participating center. All participants signed
a written informed consent.
Conceptual model and study interventions
This study was primarily based on the health belief model and
social cognitive theory. [13] The health belief model addresses an
individual’s perceptions of the threat posed by a health problem,
the benefits of avoiding the threat, and factors influencing the
decision to act. [13] Social cognitive theory assumes a reciprocal
interaction between cognitive factors (e.g. knowledge and
attitudes), environmental factors (e.g. provider recommendation),
and behaviors. Patient characteristics, such as primary diagnosis or
educational level, were considered as potential modifiers of the
effect of the intervention.
The intervention primarily targeted the knowledge deficits of
cancer survivors regarding SPC screening, but also provided
encouraging messages and information on screening participation
to address attitudes and self-efficacy. We adopted a photo-novel
format for the intervention because of the low understanding of
SPC among the study population [11] and because this format fit
our social cognitive model framework and our purpose to increase
interest among cancer survivors. [13]
Figure 1. Flowchart of study participants.
doi:10.1371/journal.pone.0033238.g001
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National Cancer Institute guidelines for designing printed
educational materials for screening [13]. The printed material
was 21 pages in length and featured colorful graphics and easy-to-
read text. It was designed to enable 100% comprehension at the
10
th grade level and used amateur actors instead of real cancer
survivors. The material included a 17-page photo-novel with the
story of a female breast cancer survivor who attended a support
group meeting and heard from a friend that another survivor was
recently diagnosed with colorectal cancer. The main character was
confused about the nature of the new cancer and thought that it
could be a breast cancer metastasis, but the friend clarified that it
was a newly developed colorectal cancer. The main character then
began to worry about the occurrence of a new cancer and
consulted her physician to find out how to address this problem.
The physician explained the definition of SPC and recommended
routine screening for other common cancers. The main character
then got routine cancer screening tests and was reassured by the
physician. The printed materials also included brief summaries of
the following topics: 1) the distinction between SPC and
recurrence or metastasis; 2) the risk of developing cancer in
survivors compared to the general population; 3) the early
detection of SPC; 4) the prevention of SPC; and 5) information
on the Korean National Cancer Screening Program. [14]
Patients in the attention control group received an educational
material on the use of health supplement products. The material
was almost the same design, format, and graphics as the
intervention materials, but differed in the contents. A female breast
cancer survivor who attended a support group meeting and heard
from a friend about a health supplement which was good for cancer
survivors. The main character was confused about the safety and
effectiveness of the supplement. She thought that it was o.k. to take
asitwasmade ofnatural herb,buta friendofherrecommendherto
reconsider it. Then the main character consulted her physician to
find out whether to take the supplement or not. The physician
explained the definition of health supplements and recommended
health diet instead of taking supplements. In addition, he explained
the patient how to choose health supplement such as ingredients,
side effects, and safety. The printed materials also included brief
summaries about how to take health supplement.
Study procedures
All participants completed a self-administered pre-intervention
survey and received the corresponding intervention materials. A
pre-intervention test evaluated their knowledge, attitudes, and
practice regarding SPC screening. Details of the baseline
measurement are available elsewhere. [15]
Two weeks after receiving the intervention materials, we
conducted phone interviews with study participants to evaluate
knowledge and attitudes regarding SPC screening. After up to
three attempts to contact participants, we reached 134 (81.7%)
survivors in the intervention group and 127 (78.4%) survivors in
the attention control group.
One year after the initial contact, we performed a telephone
interview to assess SPC screening practice. We could reach 142
(86.6%) survivors in the intervention group and 144 (89.25)
survivors in the attention control group. After the final interview,
we mailed the intervention material on SPC screening to the
attention control group, and the control material on health
supplement use to the intervention group (Figure 1).
Study outcomes and measures
The primary outcome measure of the study was completion of
all appropriate screening within 2 years for cancers other than the
survivor’s primary cancer. [15] Specific criteria were defined
considering the National Cancer Screening Program in Korea,
[14] the cancer screening guidelines in Korea, [16,17,18,19]
epidemiological evidence from cancer survivors [2,20] and from
Asian populations, [12,21,22] and current cancer screening
practices in Korea [23] (Table S2). Screening tests aimed at
detecting the specific primary cancer for each cancer survivor were
excluded from each calculation. [8,15]
Questions on screening practices addressed whether individuals
had ever had exams for breast cancer (mammogram or breast
sonography), stomach cancer (endoscopy or upper gastrointestinal
series), cervical cancer (Papanicolaou test) or colorectal cancer
(fecal occult blood test, sigmoidoscopy, colonoscopy or barium
enema). As patients had difficulties with the description of different
screening tests, [24] the questions included relevant explanations
and were simplified so that patients did not have to identify the
specific type of screening test (e.g., we asked ‘‘Have you ever had a
stomach screening test? Stomach cancer screening tests include
gastrofibroscopy or upper gastrointestinal series’’). At the baseline
survey, the patients were also provided with relevant pictures (e.g.,
patients getting gastrofibroscopy). A positive answer to any
screening question was followed by questions about the timing of
the most recent exam (less than 1 year, 1–2 years, 2–5 years, .5
years, or none).
The secondary outcome measures were the knowledge and
attitude regarding SPC screening at the 2-week interview (Table
S3). The questionnaires on knowledge and attitudes were
developed based on our qualitative studies and were pre-tested
on 5 survivors. The knowledge questionnaire included 5 true-false
questions covering: 1) occurrence of SPC; 2) difference between
‘routine surveillance test’ and ‘second cancer screening’; 3) cancer
screening needs and recommendations for cancer survivors; 4) risk
of developing SPC; and 5) meaning of routine surveillance tests
(blood test and chest X-ray). Correct answers were given 1 point,
and ‘‘Don’t know’’ responses were treated as incorrect. The
Cronbach a for the baseline assessment of knowledge was 0.23,
reflecting the heterogeneity of the items [25] and the lack of
familiarity of survivors with the topic [26]. The scores for all
questions on attitude were averaged for each participant.
The attitude questionnaire included six questions on: 1) needs
for cancer screening; 2) intention to have screening; 3) intention to
have screening following physicians’ recommendation; 4) per-
ceived health benefits; 5) perceived benefits for the family; and 6)
perceived benefits of cancer screening. Responses were recorded
on 4-point scale (strongly agree=3, agree=2, disagree=1,
strongly disagree=0) and the scores for all questions on attitude
were averaged for each participant. The Cronbach a for the
baseline assessment was 0.81.
In addition, we also conducted a brief process evaluation among
participants two weeks after the intervention. Intervention
exposure was assessed by asking whether the respondent had
looked at the material. Potential responses were ‘did not have a
look at all’, ‘browsed it quickly’, ‘read it through’, and ‘read it
carefully in detail’. Follow-up interviewers were not blinded to
intervention assignment.
Sample size and statistical analysis
Based on published screening rates, [9,27] we assumed the SPC
screening completion rate in the cancer survivors would be
approximately 40%. We determined that 326 subjects would be
required to detect an absolute difference of 20% in completion of
all appropriate screening with a power of 90%, a two-tailed a of
0.05, and 20% of losses to follow-up.
Intervention on Second Cancer Screening
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in the intervention and control groups using x
2 tests for categorical
variables and t-tests for continuous variables. All analysis of study
outcomes were performed by intention-to-treat. We compared the
primary outcome (i.e. screening behavior) in the intervention and
control groups using x
2 tests and secondary outcome measures (i.e.
knowledge and attitudes) using t-tests. A two-sided P value of
,0.05 was used to determine statistical significance. All analyses




The baseline characteristics of the survivors in the control and
intervention groups are presented in Table 1. Although the two
groups were similar at baseline, survivors in the intervention group
were significantly more likely to be married than those in the
control (92.9% vs. 85.0%). The two groups did not differ
significantly on baseline knowledge, attitudes, and behaviors
regarding cancer screening (Table 2). At the 2-week and 1-year
follow-ups there were no differences in drop-out rates between the
intervention and the attention control groups (data not shown).
Process evaluation
Among 134 survivors in the intervention group who were
reached 2 weeks after the intervention, 115 (85.8%) replied that
they had read the material. Most of them found the material easy
to follow (70.4%), recommendable to other survivors (61.7%), and
helpful or very helpful for planning future cancer screening
(88.6%) (Table 3).
Efficacy of the intervention
After 2 weeks, the knowledge score in the intervention group
was significantly higher than in the control group (mean [SD] 0.81
(0.18) vs. 0.75 (0.21); P,0.01), while there was no significant
difference in attitude score (mean [SD] 2.64 (0.38) vs. 2.57 (0.46);
P=0.18). After 1 year of follow-up, completion of all appropriate









Age, years (mean, SD) 56.4, 9.6 57.5, 10.3 0.32
Sex
Female 92 (56.1) 102 (63.0) 0.21
Male 72 (43.9) 60 (37.0)
Marital status
Single/Divorced/Separated 12 (7.4) 24 (15.0) 0.03
Married 151 (92.6) 136 (85.0)
Level of education
,12 years 46 (28.2) 41 (25.6) 0.60
$12 years 117 (71.8) 119 (74.4)
Monthly income (KRW)
,3,000,000 85 (53.1) 86 (54.8) 0.77
$3,000,000 75 (46.9) 71 (45.2)
Employment
Unemployed 88 (54.0) 100 (62.5) 0.12
Employed 75 (46.0) 60 (37.5)
Time since diagnosis, years
(mean, SD)
3.3 (2.0) 3.4 (2.1) 1.00
1–2 year 56 (34.1) 57 (35.2) 0.84
.2 years 197 (65.9) 105 (64.8)
Cancer type
Stomach 31 (18.9) 30 (18.5) 0.99
Breast 42 (25.6) 43 (26.5)
Colon 60 (36.6) 60 (37.0)
Thyroid 31 (18.9) 29 (17.9)
Stage
I 76 (46.3) 69 (42.6) 0.79
II 40 (24.4) 42 (25.9)
III 48 (29.3) 51 (31.5)
Comorbidities
Yes ($1) 91 (55.5) 93 (57.8) 0.68
No 73 (44.5) 68 (42.2)
Current smoking
Yes 8 (5.0) 4 (2.6) 0.26
No 153 (95.0) 152 (97.4)
Current drinking
Yes 37 (22.7) 29 (18.2)
No 126 (77.3) 130 (81.8) 0.32
Perceived health
Good, Very good 66 (40.2) 72 (45.6)
Very poor, Poor, Fair 98 (59.8) 86 (54.4) 0.33
Values in the table are number (percentage) unless otherwise indicated.
S.D.: Standard deviation; KRW: Korean Won.
P-values from t-tests for continuous variables or x
2 tests for categorical
variables.
doi:10.1371/journal.pone.0033238.t001
Table 2. Knowledge, attitudes, and screening practices of






Knowledge and attitudes at
baseline
Knowledge, mean (SD) 0.75 (0.19) 0.74 (0.22) 0.89
Attitude, mean (SD) 2.68 (0.43) 2.67 (0.40) 0.69
Screening practice at baseline
Gastric cancer screening
(n=265), N (%)
80 (60.2) 87 (65.9) 0.33
Breast cancer screening
(n=109), N (%)
46 (72.0) 32 (54.2) 0.06
Colon cancer screening
(n=206), N (%)
35 (33.7) 37 (36.3) 0.69
Cervix cancer screening
(n=194), N (%)
58 (64.1) 68 (66.7) 0.71
Completion, N (%) 64 (39.0) 59 (36.4) 0.63
Values in the table are number (percentage) unless otherwise indicated.
S.D.: Standard deviation.
Completion: completion of all appropriate second cancer screening in the last 2
years (for details, please see text).
P-values from t-tests for continuous variables or x
2 tests for categorical
variables.
doi:10.1371/journal.pone.0033238.t002
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(67/142) and control groups (68/144). There was also no
significant difference between two groups for each screening test
(Table 4). Sensitivity analysis which excluded those who
completed all appropriate screening within 1 year at baseline
(76/326, 23.3%) did not affect the results (data not shown). Per-
protocol analysis limited to patients who had read the material
through or carefully generated similar results (data not shown). A
pre-post comparison of screening rates showed significant increase
in the completion of all appropriate cancer screening from baseline
to one year of follow-up (39.5% vs. 47.2%; P=0.02), primarily due
to an increase in colorectal cancer screening (37.2% to 48.3%;
P,0.01) (Table 5).
Discussion
To our knowledge, this is the first trial targeted to this specific
population. We found that the educatinal material was effective for
increasing knowledge of SPC screening. However, it did not
promote cancer screening practice among cancer survivors. The
strengths of our study include the development of educational
materials based on previous qualitative studies and theoretical
Table 3. Process evaluation of study intervention.





Have you read the material? 0.94
No 19 (14.2) 21 (16.5)
Browsed it 3 (2.2) 2 (1.6)
Read it through 52 (38.8) 48 (37.8)
Read it carefully in detail 60 (44.7) 56 (44.1)







Was the material easy to understand? 0.89
Easy to follow 81 (70.4) 77 (72.6)
Intermediate difficulty 28 (24.4) 23 (21.7)
Hard to understand 6 (5.2) 6 (5.7)
Would you recommend the material to other survivors? 0.22
Yes 71 (61.7) 57 (53.8)
Uncertain 28 (24.4) 37 (34.9)
No 16 (13.9) 12 (11.3)
Was it helpful to plan your future cancer screening? NA
Very helpful 25 (21.9)
Helpful 76 (66.7)
Somewhat helpful 12 (10.5)
Not helpful at all 1 (0.9)
P-values from x
2 tests or Fisher’s exact tests when indicated.
doi:10.1371/journal.pone.0033238.t003
Table 4. Comparison of outcomes between intervention and control group.
Characteristics Intervention Control P-value
Knowledge and attitudes at 2 weeks after intervention (n=134) (n=127)
Knowledge, mean (SD) 0.81 (0.18) 0.75 (0.22) ,0.01
Attitude, mean (SD) 2.64 (0.38) 2.57 (0.46) 0.18
Screening practice at 1 year after intervention (n=142) (n=144_
Gastric cancer screening (n=233), N (%) 77 (67.5) 80 (67.2) 0.96
Breast cancer screening (n=94), N (%) 32 (72.7) 28 (56.0) 0.09
Colon cancer screening (n=180), N(%) 42 (47.2) 45 (49.5) 0.76
Cervix cancer screening (n=168), N (%) 52 (66.7) 60 (66.7) 1.00
Completion (n=286), N(%) 67 (47.2) 68 (47.2) 1.00
S.D.: Standard deviation.
Completion: completion of all appropriate second cancer screening in the last 2 years (for details, please see text).
P-values from t-tests for continuous variables or x
2 tests for categorical variables.
doi:10.1371/journal.pone.0033238.t004
Intervention on Second Cancer Screening
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biases, and the low attrition rate.
Distributing a photo-novel educational material during clinic
visits is an attractive strategy because it can be broadly
implemented at low cost. This strategy, however, was found
ineffective for increasing SPC screening rates. There might be
several reasons for the lack of efficacy. First, our simple
intervention targeted at increasing knowledge may be insufficient
to achieve a measurable impact on SPC screening. Although we
observed a small but significant effect on knowledge, a single
educational material unaccompanied by other supporting and
reinforcing components constitutes a weak stimulus, probably
insufficient for changing complex behavior. [13] Survivors did not
discuss the educational materials with health care professionals (eg,
health educators) in face-to-face or telephone interviews, which
could have provided opportunities to increase knowledge, ask
questions, reinforce their motivation, and facilitate the actual
uptake process. Our findings are consistent with a recent
systematic review of the US Agency for Healthcare Research
and Quality which found that small media interventions, defined
as print or video educational materials mailed or provided without
decision aids, generally have not been effective in improving
cancer screening rates. [28]
Second, our intervention did not incorporate logistical support,
such as direct provision of services or personalized guidance for
actual screening. Our recent qualitative study showed that
oncologists are not knowledgeable about SPC screening and they
do not directly provide screening tests to their patients (unpub-
lished data). In addition, although Korea has a national cancer
screening program, patients have to arrange their own tests as
there is no designated primary care provider to arrange cancer
screening in Korea. So, to be successful our intervention may
require additional patient actions that may need further support
and logistical organization. [29]
Third, our results also suggest the possibility of contamination in
the attention control group as the screening rate increased during
the trial period regardless of the group assignment. Survivors in
the control group may have had the opportunity to think about
second cancers through administration of study questionnaires at
baseline and at two weeks, and may have opted for further cancer
screening even without complete knowledge of SPC screening.
Media coverage of SPC risk in cancer survivors during the study
period based on a previous epidemiological study in Korea [2]
may have been another potential source of contamination.
There are some limitations. The assessment of cancer screening
practices was based on participants’ self-report, which may be
subject to over- or underreporting [30]. Surveys are the most
common methods for monitoring screening compliance [30], and
we used carefully phrased questions to maximize accuracy without
requiring survivors to distinguish among similar tests. In addition,
we conducted the study at two major cancer centers in the Seoul
metropolitan area, and the results may not be generalized to all
Korean cancer survivors who may be less educated or living in
other communities.
As a first study of its kind in this population, our study
provides important insights into the efficacy of interventions
aimed at increasing SPC screening and suggests the need for
more resource-intensive strategies to actively engage survivors
and encourage SPC screening. Promising alternatives which
have been used with some success in promoting cancer screening
include one-on-one [31] or group education, [32] telephone
outreach, [33] and patient navigators. [34] The lack of efficacy
of our patient-based intervention also suggests the need for
future research into system-level interventions (eg, using
nonclinicians to support screening [35]) or provider-directed
approaches (eg, physician reminders [36,37] or performance
feedback [38]). In addition to SPC, cancer survivors face
multiple challenges after treatment of the primary cancer and
discordant expectations with respect to the roles of oncologists
and primary care physicians can lead to deficiencies in clinical
care after completion of treatment for the primary cancer [39].
Clarifying the roles and responsibilities of the different levels of
care, providing navigation support for the patient, shared care,
[40] and routine visit to primary care physicians [10,41] could be
potential approaches to improve SPC screening in this
population.
In conclusion, this study does not support the use of simple
educational materials to increase SPC screening practices among
cancer survivors, although we observed a small but significant
improvement in SPC knowledge. Given the low rates of SPC
screening, more intensive interventions for patients and physicians
and system-levels interventions to facilitate SPC screening need to
be explored and tested among cancer survivors.
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Table S1 Incidence and 5 year relative survival rates of four
cancers in Korea.
(DOC)
Table S2 Korean recommendations and operational definition
of appropriate cancer screening used in this study.
(DOCX)
Table 5. Change in the SPC screening behavior in the






All (N=233) 150 (64.4) 157 (67.4) 0.49
Intervention group (N=118) 72 (63.2) 77 (67.5) 0.42
Control group (N=119) 78 (65.5) 80 (67.2) 0.85
Breast cancer screening
All (N=94) 59 (62.8) 60 (63.8) 1.00
Intervention group (N=44) 32 (72.7) 32 (72.7) 1.00
Control group (N=50) 27 (54.0) 28 (56.0) 1.00
Colon cancer screening
All (N=180) 67 (37.2) 87 (48.3) ,0.01
Intervention group (N=89) 33 (37.1) 42 (47.2) 0.08
Control group (N=91) 34 (37.4) 45 (49.5) 0.05
Cervix cancer screening
All (N=168) 112 (66.7) 112 (66.7) 1.00
Intervention group (N=78) 51 (65.4) 52 (66.7) 1.00
Control group (N=90) 61 (67.8) 60 (66.7) 1.00
All appropriate cancer screening
All (N=286) 113 (39.5) 135 (47.2) 0.02
Intervention group (N=142) 58 (40.8) 67 (47.2) 0.18
Control group (N=155) 55 (38.2) 68 (47.2) 0.07
P-value for difference between baseline and 1 year by McNemar tests for
matched sample.
doi:10.1371/journal.pone.0033238.t005
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regarding second cancer screening.
(DOCX)
Protocol S1 Trial Protocol.
(PDF)
Checklist S1 CONSORT Checklist.
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